SOLIS Partners with Luna PR, Award-Winning Public Relations and Marketing Agency
Los Angeles, California–(Newsfile Corp. – April 28, 2022) – SOLIS is excited to announce its…
News
Kandiyohi Power Cooperative Validates Integration of Tantalus’ TUNet Technology with Neptune’s R900 System Data
Utility generates incremental revenue stream by providing billing data to the neighboring utility operated by…
BWZ Media Acquires London-Based SaaS Lead-Generation Company Crozdesk
The acquisition further strengthens the Vancouver media company’s technology solutions and monetization capabilities VANCOUVER, British…
ShangBay Capital’s William Dai Named to GrowthCap’s 2022 Top 25 Healthcare Investors List
PALO ALTO, Calif.–(BUSINESS WIRE)–ShangBay Capital, a venture capital firm focused on investing in healthcare companies,…
Arable and Bayer Partner to Accelerate Agriculture’s Digital Transformation & Tailor Plant Genetics to In-field Conditions
SAN FRANCISCO–(BUSINESS WIRE)–Arable and Bayer announced today a partnership to accelerate digital transformation in agriculture…
SpineGuard Announces Its Full-Year 2021 Financial Results and Its First Quarter 2022 Sales
Improved net result and US operations profitable Strengthened investments for innovation Cash runway over 24…
Breeze Airways™ Announces the Appointments of Tom Doxey as President and Natalie Atwood as Chief People Officer
— President is New Position for the Young, Growing Airline; Current CPO & General Counsel…
TEGNA Announces Quarterly Dividend
TYSONS, Va.–(BUSINESS WIRE)–TEGNA Inc.’s (NYSE: TGNA) Board of Directors declared a regular quarterly dividend of…
CORRECTION: Orion Group Interim Report 1–3/2022
ORION CORPORATION INTERIM REPORT 1–3/2022 28 APRIL 2022 at 16:00 EEST CORRECTION: Orion Group Interim Report 1–3/2022 This…
Scilex Holding Company a Majority-Owned Subsidiary of Sorrento Therapeutics, Inc., Appoints Highly Accomplished Life Science Executive, Elizabeth Czerepak, as Executive Vice President, Chief Financial Officer (CFO) and Chief Business Officer (CBO)
SAN DIEGO and PALO ALTO, Calif., April 28, 2022 (GLOBE NEWSWIRE) — Scilex Holding Company…
XBiotech Announces French National Agency (ANSM) Approval and National Cancer Institute (INSA) funding to Support Phase I/II/III Clinical Study for Natrunix™ in Combination with Trifluridine/Tipiracil (TASKIN) for Treatment of Metastatic Colorectal Cancer
ANSM approves NATRUNIX for INSA funded Phase-I-III Study at 20 Leading Medical Centers in France…
Mountain Valley MD Holdings Provides Business Update
TORONTO, April 28, 2022 (GLOBE NEWSWIRE) — Mountain Valley MD Holdings Inc. (the “Company” or…
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
LONDON and PHOENIX, April 28, 2022 (GLOBE NEWSWIRE) — AccuStem Sciences, Inc. (OTCQB: ACUT), a…
ABVC BioPharma Completes Site Initiation Visits and Begins Enrollments for ADHD Phase II Part 2 Clinical Study
FREMONT, CA, April 28, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ:…
Allogene Therapeutics Appoints Susan Lundeen as Chief People Officer
New Position Aimed at Attracting, Retaining, and Cultivating a Best-in-Class Workforce as Allogene Scales its…
AVEO Oncology to Announce First Quarter 2022 Financial Results and Host Conference Call and Webcast on May 5, 2022
BOSTON, April 28, 2022 (GLOBE NEWSWIRE) — AVEO Oncology (Nasdaq: AVEO), a commercial stage, oncology-focused biopharmaceutical…
Recent Alimera Data Featured in Scientific Programming at Upcoming Annual Congress
Follow up ILUVIEN® PALADIN data to be presented onsite at the annual Association for Research…
T2 Biosystems Announces Formation and Members of Scientific Advisory Board
LEXINGTON, Mass., April 28, 2022 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the…
Veru to Report Fiscal 2022 Second-Quarter Financial Results, Host Conference Call on May 12th
MIAMI, April 28, 2022 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a biopharmaceutical company, today…
Neuronetics to Report First Quarter 2022 Financial and Operating Results and Host Conference Call
MALVERN, Pa., April 28, 2022 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage…